Physician

Frederick S Tan, MD

According to 2025 Medicare claims, Frederick Tan, MD (NPI: 1689698615) practices nephrology in the College Station-Bryan, TX market, with the plurality of this provider's patient population coming from Brazos, TX. Tan uses personal NPI as billing NPI and primary practice location at 77802-1905. Tan is affiliated with the Baylor Scott & White Quality Alliance (ACO ID: A2542) and Main Street Rural Health Hickory ACO LLC (ACO ID: A5334), participating under the MSSP model.

Tan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 483 traditional Medicare patients, billed 2,472 HCPCS/CPT codes, and received $216,995 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 2,328 prescription claims across 425 beneficiaries totaling $376,470 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 189 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $711,290 to $216,995. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $2,065,586 to $376,470. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,023 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	932	8,659	$711,290
2016	896	8,250	$663,993
2017	854	7,579	$592,677
2018	765	6,990	$631,586
2019	731	6,435	$558,340
2020	643	5,480	$486,244
2021	611	4,593	$435,398
2022	560	3,617	$326,127
2023	550	2,979	$276,670
2024	483	2,472	$216,995

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	491	4,616	$2,065,586
2016	465	4,284	$2,359,697
2017	423	3,465	$2,286,371
2018	388	2,689	$975,646
2019	425	2,777	$710,268
2020	395	2,429	$554,044
2021	362	2,149	$533,397
2022	364	2,191	$367,349
2023	381	2,190	$431,262
2024	425	2,328	$376,470

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	204	$13,727
2016	N/R	224	$15,441
2017	N/R	236	$14,963
2018	24	354	$23,542
2019	N/R	375	$23,276
2020	N/R	311	$14,046
2021	N/R	315	$12,443
2022	N/R	188	$6,045
2023	N/R	207	$5,090
2024	N/R	189	$3,979

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	58	413	$241
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	61	61	$87
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	64	64	$66
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	318	653	$53
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	115	580	$53

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	80	2,592	$179,418
Sevelamer Carbonate	Sevelamer Carbonate	96	6,711	$42,244
Lanthanum Carbonate	Lanthanum Carbonate	29	1,770	$26,384
Eliquis	Apixaban	20	935	$15,679
Calcitriol	Calcitriol	446	36,281	$11,326

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	26	$1,287
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	39	$952
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	49	$715
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	39	$696
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	15	$312

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Frederick S. Tan, MD?

Tedicare shows public-source Medicare data for Frederick S. Tan, MD (NPI 1689698615), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Frederick S. Tan, MD have ACO affiliation data?

Frederick S. Tan, MD is shown with ACO affiliation data for Baylor Scott & White Quality Alliance (MSSP, ACO ID A2542) and Main Street Rural Health Hickory ACO LLC (MSSP, ACO ID A5334).

What billing organization is linked to Frederick S. Tan, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Frederick S. Tan, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.